Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone PCA vs conventional morphine analgesia for perioperative pain control in tumor thermal ablation
ChiCTR2300076865Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in cancer pain (2 arms), sponsored by Union Hospital. Primary endpoint: The highest intraoperative pain score. Started Jan 2024; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2300076865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076865.